Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12609000216213
Ethics application status
Approved
Date submitted
24/04/2009
Date registered
29/04/2009
Date last updated
5/07/2012
Type of registration
Prospectively registered

Titles & IDs
Public title
Clinical Effectiveness of using Mindfulness-Based Cognitive Therapy to Improve Coping and Quality of Life for Stroke Survivors.
Scientific title
Clinical Effectiveness of using Mindfulness-Based Cognitive Therapy to Improve Coping and Quality of Life for Stroke Survivors.
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Stroke 4660 0
Condition category
Condition code
Mental Health 4967 4967 0 0
Depression
Stroke 4994 4994 0 0
Ischaemic

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Mindfulness-Based Cognitive Therapy (MBCT).
Mindfulness is a technique or "mode of being" that is about accepting and being content in the present moment with a non-judgemental and curious attitude. The MBCT group program involves attending 8-weekly group therapy sessions (2 hour duration). Groups will consist of a maximum of 10 participants at any one time. The group program is modified and adapted from Jon Kabat-Zinn's Mindfulness Based Stress Reduction (MBSR) work.
Intervention code [1] 4426 0
Treatment: Other
Comparator / control treatment
Waitlist Controls will not be required to change their daily routines over a 10 week period. At the end of this 10 week period they will be offered the opportunity to participate in the MBCT group program that will be exactly the same as that received by the participants in the MBCT group program condition.
Control group
Active

Outcomes
Primary outcome [1] 5818 0
Improvement in four quality of life (QoL)domains (health and functioning, social and economic, psychological and spiritual and family) as measured by the "Stroke Version of QoL" questionnaire.
Timepoint [1] 5818 0
One week prior to commencement of MBCT group program (initial interview), Week 8 (final group session) and 3-months followup.
Secondary outcome [1] 241818 0
Improvements in Mindfulness Skills utilized by the participants which will be measured by the "Mindfulness Attention Awareness Scale (MAAS)" questionnaire.
Timepoint [1] 241818 0
One week prior to commencement of MBCT group program (initial interview), Week 8 (final group session) and 3-months followup.

Eligibility
Key inclusion criteria
30 Stroke survivors who are at least six months post stroke
Minimum age
18 Years
Maximum age
65 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Stroke survivors will be excluded from the study if they suffer from delusional or psychotic thinking, have a significant cognitive deficit, or have concurrent head injury.

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Who is / are masked / blinded?



Intervention assignment
Other design features
Phase
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
24/05/2009
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
30
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)

Funding & Sponsors
Funding source category [1] 4848 0
University
Name [1] 4848 0
Neurotrauma Research Program Grant -
Western Australian Institute for Medical Research (WAIMR)
Country [1] 4848 0
Australia
Primary sponsor type
University
Name
WA Institue of Medical Research (WAIMR)
Address
University of Western Australia
B Block, Sir Charles Gairdner Hospital Nedlands WA 6009
Country
Australia
Secondary sponsor category [1] 4384 0
None
Name [1] 4384 0
Address [1] 4384 0
Country [1] 4384 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 6904 0
Sir Charles Gairdner Human Human Research Ethics Committee
Ethics committee address [1] 6904 0
Ethics committee country [1] 6904 0
Australia
Date submitted for ethics approval [1] 6904 0
Approval date [1] 6904 0
Ethics approval number [1] 6904 0
Trial # 2008-115
Ethics committee name [2] 6905 0
Curtin University of Technology Human Research Ethics Committee
Ethics committee address [2] 6905 0
Ethics committee country [2] 6905 0
Australia
Date submitted for ethics approval [2] 6905 0
Approval date [2] 6905 0
Ethics approval number [2] 6905 0
HR 22/2009

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 29531 0
Address 29531 0
Country 29531 0
Phone 29531 0
Fax 29531 0
Email 29531 0
Contact person for public queries
Name 12778 0
Dr Michelle Byrnes
Address 12778 0
School of Psychology
Curtin University of Technology
GPO Box U1987
WA 6845
Country 12778 0
Australia
Phone 12778 0
+61 8 9266 2366
Fax 12778 0
Email 12778 0
M.Byrnes@curtin.edu.au
Contact person for scientific queries
Name 3706 0
Dr Michelle Byrnes
Address 3706 0
School of Psychology
Curtin University of Technology
GPO Box U1987
WA 6845
Country 3706 0
Australia
Phone 3706 0
+61 8 9266 2366
Fax 3706 0
Email 3706 0
M.Byrnes@curtin.edu.au

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.